Benzoyl Peroxide
Brand Names: Zapzyt Acne Treatment Gel, Acne Face and Body, Age Intervention Duality, Bubble Fade Away Acne Spot Treatment, Breakout Control Bioelements, Spotless Acne Clearing Treatment
Methodology & AI Transparency ⓘ
Benzoyl Peroxide Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: 1 Indications and usage epsolay: is indicated for the treatment of inflammatory lesions of rosacea in adults.
- 2 Real-world patient consensus: Zero-PHI community consensus: 81% favorable across 17 logged regimens (Zapzyt Acne Treatment Gel, Acne Face and Body).
- 3 Typical cash cost range: 30-day cash pricing ranges from $16.64 discount cash to $40.77 walk-in retail (NADAC $0.2009/unit).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Benzoyl Peroxide include peripheral edema (4.6%), application-site irritation (7.4%), nausea (7.5%).
Ask our AI Specialists anything about Benzoyl Peroxide
Benzoyl Peroxide Mechanism, CYP450 Pathways & DailyMed Monograph
1 Indications and usage epsolay: is indicated for the treatment of inflammatory lesions of rosacea in adults. EPSOLAY is indicated for the treatment of inflammatory lesions of rosacea in adults. ( 1 )
12.1 Mechanism of Action Benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic effects but the precise mechanism of action in the treatment of rosacea is unknown.
With Negligible circulating terminal half-life following local Benzoyl Peroxide application residence kinetics and < 5% transdermal or mucosal systemic uptake from Benzoyl Peroxide bioavailability, Benzoyl Peroxide undergoes local esterase/enzymatic cleavage of benzoyl peroxide with minimal hepatic cytochrome burden and establishes therapeutic activity over initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (benzoyl peroxide).
Standard adult regimens span 50 mg/mL Cream, 100 mg/g Soap, 25 mg/g Gel, 5 g/100mL Cream, .2 g/50g Cream. Prescribers screen specifically against 4 contraindications epsolay is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in epsolay .; a history of a serious hypersensitivity reactions to benzoyl peroxide or any component of the formulation in epsolay., while community micro-logs most frequently note nausea (7.5% of reports), application-site irritation (7.4% of reports), headache (6.6% of reports).
Reconcile eGFR-adjusted medications before escalating Benzoyl Peroxide in polypharmacy regimens.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Benzoyl Peroxide dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- 4 CONTRAINDICATIONS EPSOLAY is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in EPSOLAY .
- A history of a serious hypersensitivity reactions to benzoyl peroxide or any component of the formulation in EPSOLAY.
Logged Side-Effect Incidence (17 Reports)
Benzoyl Peroxide Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Benzoyl Peroxide)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of microencapsulated benzoyl peroxide and microencapsulated: What a 571-Participant Study Found E-BPO/T provided statistically significant and clinically relevant improvements in IGA and inflammatory and noninflammatory lesion counts and was well tolerated in subjects with moderate to severe acne. Journal of the American Academy of Dermatology • 2023-10-15 • Phase III Randomized Trial | N = 571 | 93/100 | PMID 37356627 ↗ |
| New Insights on Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate: What a 741-Participant Study Found Lesion count reductions were significantly greater with CAB versus its dyads and vehicle gel as early as week 4, with substantial reductions observed after 12 weeks of treatment. Journal of drugs in dermatology : JDD • 2024-03-01 • Phase III Randomized Trial | N = 741 | 93/100 | PMID 38443130 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of fixed-dose clindamycin phosphate 1.2%/adapalene This study provides support for acne treatment with CAB in ethnically diverse populations. The Journal of dermatological treatment • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40122140 ↗ |
| Can This Approach Help? Inside the Latest Research on Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide At week 12, treatment success rates for both children and adult participants were significantly greater with CAB (52.7%; 45.9%) than with vehicle (24.0%; 23.5%; P<0.01, both). Journal of drugs in dermatology : JDD • 2024-06-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38834226 ↗ |
| New Insights on Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne:: What a 241-Participant Study Found In 3 clinical trials, CAB, the only fixed-dose, triple-combination applied to the skin for acne, demonstrated ≥70% lesion reductions, with good tolerability regardless of participants' sex or age. Journal of drugs in dermatology : JDD • 2026-08-01 • Phase III Randomized Trial | N = 241 | 88/100 | PMID 42555077 ↗ |
Benzoyl Peroxide Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.2009/unit (~$6.03/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $40.77 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 17 Anonymous DotMD Community Micro-Logs | $16.64 / mo | View logs ↓ |
Benzoyl Peroxide Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Benzoyl Peroxide RxNorm Concept ID | 106315 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.2009 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $40.77 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $16.64 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 81.00% Worth It (17 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Benzoyl Peroxide Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Benzoyl Peroxide: FDA labeling (2025-08-11, NDC 71687-0011), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Benzoyl Peroxide community threads and patient logs by age, biological sex, dosage, and treatment duration.